Melanoma Risk-Reduction Among Patients and Family Members
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Skin Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/16/2019 |
| Start Date: | November 2002 |
| End Date: | November 2019 |
Melanoma Risk-Reduction Practices Among Melanoma Patients and Their Family Members
Primary Objectives:
- To conduct semi-structured interviews with melanoma patients and family members to
collect descriptive information on their UVR exposure, UVR exposure-reduction practices,
melanoma early detection practices, knowledge, psychosocial variables related to
melanoma risk-reduction (e.g., self-efficacy, norms, and expectations), and experiences
surrounding the diagnosis of melanoma in the family. Melanoma patients and family
members with children will be asked about the UVR exposure and UVR exposure-reduction
practices of their children, and parental practices to reduce UVR exposure among
children.
- To develop behavioral and attitudinal questionnaires based on data collected during
semi-structured interviews, and evaluate the appropriateness of these questionnaires
using cognitive interviewing techniques.
- To develop tailored messages aimed at promoting strategies to reduce UVR exposure (e.g.,
wearing protective clothing, minimizing midday UVR exposure, minimizing duration of UVR
exposure, using shade and sunscreen, avoiding sun lamps, and avoiding intentional
tanning) and improving adherence to surveillance and screening guidelines. Messages will
be developed to correspond to responses to questionnaire items.
- To assess tailored messages for their relevance, appropriateness, attractiveness and
appeal, credibility, and perceived behavioral impact among melanoma patients and their
family members.
- To conduct semi-structured interviews with melanoma patients and family members to
collect descriptive information on their UVR exposure, UVR exposure-reduction practices,
melanoma early detection practices, knowledge, psychosocial variables related to
melanoma risk-reduction (e.g., self-efficacy, norms, and expectations), and experiences
surrounding the diagnosis of melanoma in the family. Melanoma patients and family
members with children will be asked about the UVR exposure and UVR exposure-reduction
practices of their children, and parental practices to reduce UVR exposure among
children.
- To develop behavioral and attitudinal questionnaires based on data collected during
semi-structured interviews, and evaluate the appropriateness of these questionnaires
using cognitive interviewing techniques.
- To develop tailored messages aimed at promoting strategies to reduce UVR exposure (e.g.,
wearing protective clothing, minimizing midday UVR exposure, minimizing duration of UVR
exposure, using shade and sunscreen, avoiding sun lamps, and avoiding intentional
tanning) and improving adherence to surveillance and screening guidelines. Messages will
be developed to correspond to responses to questionnaire items.
- To assess tailored messages for their relevance, appropriateness, attractiveness and
appeal, credibility, and perceived behavioral impact among melanoma patients and their
family members.
Participants in Part 1 of the study will be asked to be interviewed about topics related to
melanoma risk-reduction, including opinions, attitudes, beliefs, and practices related to
ultraviolet radiation exposure, melanoma prevention, and melanoma detection.
Participants in Part 2 of the study will be asked to complete a written questionnaire on
melanoma risk-reduction and then be interviewed to obtain feedback on how the questionnaire
may be refined.
Participants in Part 3 of the study will be asked to be interviewed by telephone.
Participants then will receive educational material in the form of a newsletter tailored to
their interview responses. Participants then will be asked to be interviewed to obtain
feedback for refining the educational material. In each part of the study, the patient/family
member will receive a letter describing the study and the Consent Statement for Questionnaire
and Interview Studies.
Prior to the start of the interview, the Consent Statement will be read to the patient/family
member. Patients/family members may or may not choose to have the interview tape-recorded.
Participants may stop the interview or questionnaire at any time and may refuse to answer any
questions. At any time, the patient/family member may refuse to have the interview
tape-recorded. There is no treatment associated with this study.
melanoma risk-reduction, including opinions, attitudes, beliefs, and practices related to
ultraviolet radiation exposure, melanoma prevention, and melanoma detection.
Participants in Part 2 of the study will be asked to complete a written questionnaire on
melanoma risk-reduction and then be interviewed to obtain feedback on how the questionnaire
may be refined.
Participants in Part 3 of the study will be asked to be interviewed by telephone.
Participants then will receive educational material in the form of a newsletter tailored to
their interview responses. Participants then will be asked to be interviewed to obtain
feedback for refining the educational material. In each part of the study, the patient/family
member will receive a letter describing the study and the Consent Statement for Questionnaire
and Interview Studies.
Prior to the start of the interview, the Consent Statement will be read to the patient/family
member. Patients/family members may or may not choose to have the interview tape-recorded.
Participants may stop the interview or questionnaire at any time and may refuse to answer any
questions. At any time, the patient/family member may refuse to have the interview
tape-recorded. There is no treatment associated with this study.
Inclusion Criteria:
- (FDRs will include siblings and adult children.) Melanoma patients are eligible if
they were diagnosed with in situ, localized, or regional melanoma after January 1,
1997.
- Melanoma patients, their spouses/partners, and their first-degree relatives (FDRs) 18
years of age or older are eligible.
- Melanoma patients, their spouses/partners, and FDRs are eligible if they can speak,
read, and write English.
- Melanoma patients, their spouses/partners, and FDRs are eligible if they provide
informed consent.
- Spouses/partners and FDRs of melanoma patients are eligible if the patient gives
permission for them to be contacted for recruitment.
- A melanoma patient's FDR is eligible if he/she is a sibling or child of the melanoma
patient.
Exclusion Criteria:
- Melanoma patients, spouses/partners of patients, and FDRs of patients are not eligible
if they cannot provide informed consent.
We found this trial at
1
site
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
